Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control

SARS-CoV-2 serology is useful to identify past COVID-19 cases, and it is not useful for acute infection. Levels of specific SARS-CoV-2 anti-N and especially anti-S are expected to be maintained for long periods. At this moment there is not a clear correlate of protection after COVID-19 or vaccinatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Delgado, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Update on the management of SARS-CoV-2 infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683006/
https://www.ncbi.nlm.nih.gov/pubmed/34598425
http://dx.doi.org/10.37201/req/s01.13.2021
_version_ 1784617325108920320
author Delgado, Rafael
author_facet Delgado, Rafael
author_sort Delgado, Rafael
collection PubMed
description SARS-CoV-2 serology is useful to identify past COVID-19 cases, and it is not useful for acute infection. Levels of specific SARS-CoV-2 anti-N and especially anti-S are expected to be maintained for long periods. At this moment there is not a clear correlate of protection after COVID-19 or vaccination, therefore serological follow up is not indicated in most cases.
format Online
Article
Text
id pubmed-8683006
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedad Española de Quimioterapia
record_format MEDLINE/PubMed
spelling pubmed-86830062021-12-29 Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control Delgado, Rafael Rev Esp Quimioter Update on the management of SARS-CoV-2 infection SARS-CoV-2 serology is useful to identify past COVID-19 cases, and it is not useful for acute infection. Levels of specific SARS-CoV-2 anti-N and especially anti-S are expected to be maintained for long periods. At this moment there is not a clear correlate of protection after COVID-19 or vaccination, therefore serological follow up is not indicated in most cases. Sociedad Española de Quimioterapia 2021-09-30 2021 /pmc/articles/PMC8683006/ /pubmed/34598425 http://dx.doi.org/10.37201/req/s01.13.2021 Text en © The Author 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Update on the management of SARS-CoV-2 infection
Delgado, Rafael
Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
title Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
title_full Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
title_fullStr Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
title_full_unstemmed Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
title_short Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
title_sort comprehensive serological strategy for the diagnosis and monitoring of sars-cov-2. from infection to vaccine control
topic Update on the management of SARS-CoV-2 infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683006/
https://www.ncbi.nlm.nih.gov/pubmed/34598425
http://dx.doi.org/10.37201/req/s01.13.2021
work_keys_str_mv AT delgadorafael comprehensiveserologicalstrategyforthediagnosisandmonitoringofsarscov2frominfectiontovaccinecontrol

Ejemplares similares